Averin Capital

📍 New York, United States🗓 Founded 2023👥 11 employees💰 Last funded Jun 2025
Financial Services🌐 averincapital.com
Website LinkedIn
This is the biology century. Software changed the world over the last 30 years. Technology and biology will converge over the next 30 to have an even larger impact. We focus on four key verticals: 1) Artificial Intelligence: therapeutic development platforms, diagnostic and decision support, workflow and insurance, and predictive analytics. 2) Longevity: early screening and intervention, preventative care, remote patient monitoring and care, and integrated care platforms. 3) Data-driven care: value-based care, real world data / evidence, payment integrity, and sustainable healthcare models. 4) Deep technology: synthetic biology, nanotechnology, personalized medicine, and genomics.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Canada
1
United States
1
Frequently asked questions
Who invested in Averin Capital?
Averin Capital has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Averin Capital last raise funding?
The most recent investment in Averin Capital recorded on gritt.io was in June 2025.
When was Averin Capital founded?
Averin Capital was founded in 2023.
What industry is Averin Capital in?
Averin Capital operates in Financial Services. Find similar Financial Services investors on gritt.io.
Where is Averin Capital based?
Averin Capital is headquartered in New York, United States.